These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 19861405)

  • 1. RhoC expression and head and neck cancer metastasis.
    Islam M; Lin G; Brenner JC; Pan Q; Merajver SD; Hou Y; Kumar P; Teknos TN
    Mol Cancer Res; 2009 Nov; 7(11):1771-80. PubMed ID: 19861405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RhoC regulates cancer stem cells in head and neck squamous cell carcinoma by overexpressing IL-6 and phosphorylation of STAT3.
    Islam M; Sharma S; Teknos TN
    PLoS One; 2014; 9(2):e88527. PubMed ID: 24533098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RhoC GTPase expression as a potential marker of lymph node metastasis in squamous cell carcinomas of the head and neck.
    Kleer CG; Teknos TN; Islam M; Marcus B; Lee JS; Pan Q; Merajver SD
    Clin Cancer Res; 2006 Aug; 12(15):4485-90. PubMed ID: 16899593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A definitive role of RhoC in metastasis of orthotopic lung cancer in mice.
    Ikoma T; Takahashi T; Nagano S; Li YM; Ohno Y; Ando K; Fujiwara T; Fujiwara H; Kosai K
    Clin Cancer Res; 2004 Feb; 10(3):1192-200. PubMed ID: 14871999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RhoC mediates epidermal growth factor-stimulated migration and invasion in head and neck squamous cell carcinoma.
    Tumur Z; Katebzadeh S; Guerra C; Bhushan L; Alkam T; Henson BS
    Neoplasia; 2015 Jan; 17(1):141-51. PubMed ID: 25622907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atorvastatin inhibits RhoC function and limits head and neck cancer metastasis.
    Islam M; Sharma S; Kumar B; Teknos TN
    Oral Oncol; 2013 Aug; 49(8):778-86. PubMed ID: 23648017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted disruption of protein kinase C epsilon reduces cell invasion and motility through inactivation of RhoA and RhoC GTPases in head and neck squamous cell carcinoma.
    Pan Q; Bao LW; Teknos TN; Merajver SD
    Cancer Res; 2006 Oct; 66(19):9379-84. PubMed ID: 17018591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of RhoC in ovarian epithelial carcinoma: a marker for carcinogenesis, progression, prognosis, and target therapy.
    Zhao Y; Zheng HC; Chen S; Gou WF; Xiao LJ; Niu ZF
    Gynecol Oncol; 2013 Sep; 130(3):570-8. PubMed ID: 23764197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down regulation of RhoC by microRNA-138 results in de-activation of FAK, Src and Erk1/2 signaling pathway in head and neck squamous cell carcinoma.
    Islam M; Datta J; Lang JC; Teknos TN
    Oral Oncol; 2014 May; 50(5):448-56. PubMed ID: 24565984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RhoC, vascular endothelial growth factor and microvascular density in esophageal squamous cell carcinoma.
    Zhao ZH; Tian Y; Yang JP; Zhou J; Chen KS
    World J Gastroenterol; 2015 Jan; 21(3):905-12. PubMed ID: 25624724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of invasion and metastasis of hepatocellular carcinoma cells via targeting RhoC in vitro and in vivo.
    Wang W; Wu F; Fang F; Tao Y; Yang L
    Clin Cancer Res; 2008 Nov; 14(21):6804-12. PubMed ID: 18980974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A p27(kip1)-binding protein, p27RF-Rho, promotes cancer metastasis via activation of RhoA and RhoC.
    Hoshino D; Koshikawa N; Seiki M
    J Biol Chem; 2011 Jan; 286(4):3139-48. PubMed ID: 21087931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.
    Chang XZ; Li DQ; Hou YF; Wu J; Lu JS; Di GH; Jin W; Ou ZL; Shen ZZ; Shao ZM
    Breast Cancer Res; 2007; 9(6):R76. PubMed ID: 17980029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of RhoA and RhoC expression by RNA interference suppresses human colorectal carcinoma growth in vivo.
    Wang H; Zhao G; Liu X; Sui A; Yang K; Yao R; Wang Z; Shi Q
    J Exp Clin Cancer Res; 2010 Sep; 29(1):123. PubMed ID: 20828398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of RhoC in growth and metastatic capacity of melanoma.
    Boone B; Van Gele M; Lambert J; Haspeslagh M; Brochez L
    J Cutan Pathol; 2009 Jun; 36(6):629-36. PubMed ID: 19222696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation of expression of RhoC with invasiveness of prostate cancer cell line PC-3M in vitro].
    Yuan Z; Su J; You JF; Wang JL; Cui XL; Zheng J
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(1):51-5. PubMed ID: 18346381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNF168 promotes RHOC degradation by ubiquitination to restrain gastric cancer progression via decreasing HDAC1 expression.
    Xu Y; Feng Y; Sun Z; Li Q
    Biochem Biophys Res Commun; 2021 Jun; 557():135-142. PubMed ID: 33865221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel strategy for specifically down-regulating individual Rho GTPase activity in tumor cells.
    Wang L; Yang L; Luo Y; Zheng Y
    J Biol Chem; 2003 Nov; 278(45):44617-25. PubMed ID: 12939257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of RHOC is associated with metastasis of gastric carcinomas.
    Kondo T; Sentani K; Oue N; Yoshida K; Nakayama H; Yasui W
    Pathobiology; 2004; 71(1):19-25. PubMed ID: 14555841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological Inhibition of Myocardin-related Transcription Factor Pathway Blocks Lung Metastases of RhoC-Overexpressing Melanoma.
    Haak AJ; Appleton KM; Lisabeth EM; Misek SA; Ji Y; Wade SM; Bell JL; Rockwell CE; Airik M; Krook MA; Larsen SD; Verhaegen M; Lawlor ER; Neubig RR
    Mol Cancer Ther; 2017 Jan; 16(1):193-204. PubMed ID: 27837031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.